- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Segment 11: Can Clinical Pathways Restrict Patient Access?
Neither Blase Polite, MD, MPP, not Robert Dubois, MD, PhD, believe that clinical pathways restrict patient access to care.
When asked to discuss patient access to care, Blase Polite, MD, MPP, said he would not consider pathways as restricting access for patients. At this point, he answered, pathways are not a high stake problem because there is no large compensation tied to them. As long as pathways are structured so that there is flexibility and acknowledgment that physicians do not need to be 100% compliant, Dr Polite said he is not concerned.
Robert Dubois, MD, PhD, was in complete agreement since he believes that people are implementing pathways in a gradual way. “I think it’ll be very interesting to see the evolution with the [National Comprehensive Cancer Network] pathways because now they’re beginning to develop value measures, and how tightly they will marry the 2 and whether, as we ratchet up concerns about cost, whether that means that patients will have fewer and fewer choices with their doctors,” he replied.
Dr Dubois does, however, think that this is an open question that we should keep a close eye on in the future.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Downward Morbidity, Mortality Trends Discovered Among Patients With Ovarian Cancer, Liver Metastases
April 24th 2024This study indicates a declining trend in morbidity and mortality rates among patients with ovarian cancer and liver metastases, highlighting the efficacy of surgery and chemotherapy in improving survival outcomes.
Read More
